AMN Healthcare Services Inc: Form 10-Q for the period ended Jun 30, 2017
Filed with the SEC on Aug 4, 2017 and accepted by EDGAR at Aug 4, 2017, 14:24 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-06-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-04-01 to 2017-06-30 | $328.8m | us-gaap:CostOfRevenue |
| Cost of revenue | 6 months2017-01-01 to 2017-06-30 | $662.2m | us-gaap:CostOfRevenue |
| Gross profit | 3 months2017-04-01 to 2017-06-30 | $161.0m | us-gaap:GrossProfit |
| Gross profit | 6 months2017-01-01 to 2017-06-30 | $322.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2017-04-01 to 2017-06-30 | $96.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 6 months2017-01-01 to 2017-06-30 | $198.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-04-01 to 2017-06-30 | $56.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2017-01-01 to 2017-06-30 | $108.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2017-04-01 to 2017-06-30 | $4.9m | us-gaap:InterestExpense |
| Interest expense | 6 months2017-01-01 to 2017-06-30 | $10.1m | us-gaap:InterestExpense |
| Income tax | 3 months2017-04-01 to 2017-06-30 | $20.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2017-01-01 to 2017-06-30 | $35.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-04-01 to 2017-06-30 | $31.3m | us-gaap:NetIncomeLoss |
| Net income | 6 months2017-01-01 to 2017-06-30 | $63.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-04-01 to 2017-06-30 | $0.63 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2017-01-01 to 2017-06-30 | $1.28 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-04-01 to 2017-06-30 | $0.65 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2017-01-01 to 2017-06-30 | $1.32 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2017-04-01 to 2017-06-30 | 49,475,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2017-01-01 to 2017-06-30 | 49,498,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2017-01-01 to 2017-06-30 | $70.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2017-01-01 to 2017-06-30 | $11.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 6 months2017-01-01 to 2017-06-30 | $329.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-06-30 | $22.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-06-30 | $441.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-06-30 | $1.19bn | us-gaap:Assets |
| Current liabilities | At period end2017-06-30 | $266.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-06-30 | $680.5m | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-06-30 | $508.5m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001142750-17-000010. Last ingested by Listed: Nov 5, 2026, 17:59 ET. Listed shows no prices and gives no investment advice.